Previous 10 | Next 10 |
Biofrontera is eyeing significant growth opportunities for its FDA-approved skin disease photodynamic therapy drug "Ameluz". Updates regarding several ongoing clinical studies for expanded label indications can be a catalyst for the stock in 2022. While Biofrontera maintains a pos...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Gainers: Reliance Global Group (NASDAQ:RELI) +89%. Biofrontera (NASDAQ:BFRI) +49%. IsoPlexis Corporation (NASDAQ:ISO) +37%. Chemomab Therapeutics (NASDAQ:CMMB) +29%. iSpecimen (NASDAQ:ISPC) +28%. Aldeyra Therapeutics (NASDAQ:ALDX) -51%. DBV Technologies...
Micro-cap biopharma stock, Biofrontera (BFRI +66.9%) has stretched its pre-market gains to a post-IPO high on above average volume maintaining its popularity on social media. The company did not immediately respond to Seeking Alpha’s requests for comments on the sudden move in its shar...
Gainers: Reliance Global Group (NASDAQ:RELI) +82%. Biofrontera (NASDAQ:BFRI) +49%. Jaguar Health (NASDAQ:JAGX) +43%. IsoPlexis (NASDAQ:ISO) +31%. Aridis Pharmaceuticals (NASDAQ:ARDS) +28%. Petros Pharmaceuticals (NASDAQ:PTPI) +30%. Eqonex (NASDAQ:EQOS) +26%. Quantum-Si incorporated (NASDAQ:QS...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Braze (NASDAQ: BRZE ) stock is on the move Tuesday after the company released its earnings report for the third quarter of 2021. Source: Blackboard / Shutterstock Let’s break down that earnings report b...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biofrontera (NASDAQ: BFRI ) stock is on the move today as traders take to Twitter (NYSE: TWTR ) to discuss the latest news surrounding the company. Source: Pavel Kapysh / Shutterstock The big news boosti...
Penny stocks are one of the most exciting investment vehicles in the stock market today. First, they offer a way for the market to gain exposure to start-ups without being angle investors or needing accreditation. You’ve got pre-IPO investment platforms that provide such opportun...
Reliance Global (NASDAQ:RELI) +85%. Aridis Pharmaceuticals (NASDAQ:ARDS) +72% after its antibody cocktail retains effectiveness against Omicron variant. Quoin Pharmaceuticals (NASDAQ:QNRX) +44%. Cassava Sciences (NASDAQ:SAVA) +40% Cassava Sciences, Biofrontera rise amid so...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re kicking off the day with a dive into the biggest pre-market stock movers for Tuesday! Source: ventdusud / Shutterstock.com Moving stocks this morning is Covid-19 antibody news, ear...
News, Short Squeeze, Breakout and More Instantly...
The RhodoLED XL is approved by the FDA in combination with Ameluz ® (aminolevulinic acid hydrochloride) topical gel, 10% for photodynamic therapy (PDT) of actinic keratoses of mild-to-moderate severity on the face and scalp Biofrontera launched the commercial distribution of the Rhod...
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results f...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...